North Bud Farms Announces Licensing of Cannabinoid Infusion Technology for Food and Beverage Platform
Momentum Public Relations
Press Release: September 27, 2018
North Bud Farms Inc.(CSE: NBUD) (“NORTHBUD” or the “Company”) is pleased to announce the licensing of infusion technology for its food and beverage platform with Made By Science Inc., a wholly owned subsidiary of Form Factory Inc.
The Company signed a supply and licensing agreement with Made By Science Inc. (“MBS”), an Oregon, California multi state co-packaging and infused product manufacturer. MBS owns a variety of IP protected infusion, encapsulation, taste masking and manufacturing processes.
This Agreement provides that NORTHBUD will purchase from MBS raw, non-infused protein-based encapsulation powder (MX-17) to be used for infusion and formulation purposes in the Canadian market. NORTHBUD and MBS have established a per gram cost as well as a royalty agreement where NORTHBUD will pay a floating royalty on business to business sales and a consumer direct sale.
The companies intend to negotiate a master licensing agreement (“the Agreement”) to include the licensing and use of multiple proprietary food infusion technologies for which MBS will grant a master license for NORTHBUD to the use of the patented technology.
“Over the past 8 months our team has researched many technology solutions pertaining to encapsulation and infusion of cannabinoids into foods and beverages,” said Ryan Brown, Founder and CEO of North Bud Farms Inc. “This agreement secures us access to a premier technology partner allowing us to leverage a proven technology and tested processes from an advanced consumer market. We believe this will accelerate NORTHBUD’s goal of developing a food grade cannabinoid infused taste neutral ingredient as a first step towards creating products that will follow in compliance with the upcoming regulations regarding infused consumables. Over the coming months we look forward to working with both Food and Cannabis industry participants as we establish our development platform in preparation for the legalization of edibles and consumables which is anticipated in October 2019.”
“Made By Science has been relentlessly innovating the science driving the infused edibles industry to provide brands and consumers with safe, efficient and accurate products. As our team continues to position as a best in class manufacturer in the U.S., we have had our sights set on Canada as both critical to our long-term expansion and essential for our ability to export to international markets. NORTHBUD was an early believer in our technology and our team and we are excited to support their efforts with innovation and scale,” said Joshua Held, President of Form Factory Inc.
In accordance with the corporate stock option plan, North Bud Farms has issued 85,000 options at a strike price of $0.60 to advisors and consultants assisting with this project. These options will vest over a 24-month period.
About Made By Science Inc.
Made By Science Inc. is a wholly owned subsidiary of Form Factory Inc., a multi state manufacturer of cannabis infused food and beverage products.
For more information visit: www.madebyscience.co
About North Bud Farms Inc.
North Bud Farms Inc., through its wholly-owned subsidiary GrowPros MMP Inc. which was acquired in February 2018, is pursuing a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR). North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.
For more information visit: www.northbud.com
- Published in Business, Medical Marijuana, News Home, NorthBud
AREV Shifts into High Gear — CFN Media
Momentum Public Relations
In The News: September 26, 2018
AREV Brands International (CSE: AREV) is a cannabis integrator that has parlayed its history with natural health products into an intriguing and streamlined cannabis company. Through a series of accretive acquisitions, the company has transformed into a Canadian-based cannabis operator with international ambitions.
Genetics, the Foundation of Quality and Consistency
AREV recently acquired BC Bud Depot, one of the world’s most respected and awarded breeders and marketers that features an internationally recognized brand and an extensive seed bank of hundreds of strains. Starting with 2004’s win at the High Times Cannabis Cup, the first win for a Canadian company in international competition, BC Bud Depot strains have up more than 40 awards from cannabis competitions.
Genetics and proprietary strains are important for both the medical and adult-use markets. In the medical arena, consistent and specific genetic traits produce consistent and specific terpene and cannabinoid profiles, thereby providing a remedy for a targeted area of health such as Anxiety, Central Nervous System, Insomnia, Libido and Pain Management. AREV has taken an in-depth look at the BCBD seed bank and identified several strains that deliver a specific experience to the consumer. Due to intelligent strain selection and processing, consumers can choose how they would like to feel. They can Relax, be Energized, Create, all based on easy to understand labelling.
AREV sees both wholesale and retail potential from its seed bank. The strains could be sold outright to licensed producers, or they could be the foundation of a partnership where the LP cultivates the plant and sells it back to AREV for distribution. The cultivation risk and expense is off-loaded to the growers and AREV controls the genetics. The opportunity is not limited to North America, as the company has incorporated in Ireland and Germany to build on its international infrastructure.
The BC Bud Depot acquisition also netted a couple of other key assets. One, the company has an extensive database of over 50,000 customers and potential customers, a list that is invaluable as AREV grows its business both with cultivators and in other aspects of the industry. Two, BC Bud Depot has 10 years of pre-paid advertising on the prime inside front cover of High Times magazine.
Extraction and Innovation
AREV controls 28 acres in the Southern Interior of British Columbia. It plans to leverage an ACMPR license to develop a breeding, nursery, laboratory, and extraction facility that will further expand the company’s capabilities in relation not only to cannabis but to the development of other medicinal plant-based products.
AREV cut its teeth on plant-based, scientifically derived products utilizing extracts from a variety of medicinal plants. In a joint venture with a related company, Alternative Extracts Inc., the company utilizes state of the art extraction techniques to create pure and consistent concentrates that form the foundation for nutritional and nutraceutical products. AREV recently announced that this joint venture has perfected the infusion of oil-based extracts (like the cannabinoids and terpenes from cannabis) into beverages, including beer, wine, ciders, and fruit juices. The proprietary extraction method preserves the natural characteristics of the active ingredients, including flavor.
By adjusting the terpene profiles, AREV’s CBD and THC based products can now deliver a specific experience to the consumer. This enables the company to profile the experience the consumer has while enjoying products with AREV’s ingredients. With the cannabis industry headed more toward extract-based products, both medicinally and recreationally, and away from smoked cannabis flower, a breakthrough like this could be transformative for the company. Beverages are in their infancy, and technology that can deliver all of the desirable characteristics from the flower in beverage form would certainly bring change to the beverage industry. AREV’s terpene profiling is not limited to the cannabis industry. It can be used in many food and beverage products currently sold in unregulated markets.
Products and Distribution
AREV’s COCO-MULSION products are sold in the health and wellness sector. These products come in formulations that support relaxation, brain function, and physical performance. They are Health Canada certified and distributed throughout the country. The company also has Canadian distribution rights to the Bare Topicals line of cannabis-based creams intended for pain relief and treatment of skin conditions. In the pipeline, AREV intends to launch a line of CBD sport nutrition supplements along with a CANNA-MULSION CBD with its new brand ambassador Patrick Cote, former UFC Champion. The company has also collaborated with Alternative Extracts to come up with a THC delivery system and a full line of cannabis oils and sprays.
Some of these products need the proper ACMPR licenses for distribution, while others can be offered over the counter as they derive from hemp rather than cannabis. Either way, the fact that AREV has lines of distribution in place and products currently in the market bodes well for the successful introduction of new products in the future.
Please follow the link to read the full article: http://www.cannabisfn.com/arev-shifts-high-gear/
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
- Published in AREV Nutrition Sciences, Business, Medical Marijuana, News Home
Crop Secures THC License Portfolio at New 1,000 Acre Farm for Cultivation, Extraction, Commercial Kitchen and Retail
Momentum Public Relations
Press Release: September 26, 2018
CROP INFRASTRUCTRE CORP. (CSE: CROP) (OTC: CRXPF) announces that its subsidiary Elite Ventures Group LLC has signed a joint venture agreement with The Hempire LLC of Nevada (the “Tenant”) to purchase a 100% interest in an 1,000 acre Esmeralda County agricultural cannabis project tenanted with a suite of cannabis licenses including medical cultivation, medical production and with adult use recreational cultivation & production conditional licenses as well as an option to acquire a retail dispensary application assigned to a strategic location on highway 95 on route to Las Vegas. CROP has agreed to loan up to $4,250,000 USD over a period of the next 6 months to acquire 100% of the initial 10 acres of real estate and associated infrastructure with the additional 1,000 acres being paid for at a cost of $4,500,000 over a 20-year amortization period at 6% interest with a 3-year balloon payment. CROP will receive preferential payback on the project at a rate of 60% of the net profits from Elite.
Esmerelda County is one of the only jurisdictions in Nevadawhere climate and zoning allows for greenhouse or outdoor growing. This will be significant for our tenant growers and brand licensee to be able to provide high quality product on a large scale at the lowest cost possible, keeping with CROP’s strategy.
The initial set up costs of outdoor 80-acre operation will be approximately $1,200,000 and should yield tenants 160,000 pounds of outdoor cannabis for extraction and edibles and a 44,000 square foot light supplemented greenhouse facility at a cost of $2.0 Million. The greenhouse facility should yield tenants 24,000 pounds of high quality flower per year with an additional 25% for extraction and edibles. The project can be expanded up to 300 acres of combined greenhouse and outdoor cultivation.
RBC Capital Markets, an investment bank that’s part of Royal Bank of Canada, issued a memo to clients outlining the rapid growth of the U.S. marijuana sector. The memo, authored by Nik Modi, shows how cannabis sales in the U.S. are gaining ground on beer and wine sales. Projecting a compound annual growth rate (CAGR) of 17 percent, Modi estimates that the legal cannabis category could reach $47 billion in sales annually in the United States within the next decade, according to Business Insider.
The Esmeralda Property
- 10 acres of land adjacent to Highway 95 outside of Tonopah
- 10 acre-feet of ground water rights
- Option to acquire 1,000 acres of contiguous property with water rights
- 2,400 sqft production, extraction, commercial kitchen facilities with state approval
- NV Energy Utility agreement for cultivation building and expansion to 12,000 sqft.
- Equipment included: Building, main HVAC system, lighting, backup generator, sinks, and restroom fixtures.
CROP Infrastructure Director and CEO, Michael Yorke, stated: “CROP now has over 1,000 acres for THC Cannabis cultivation, extraction, commercial kitchen and 1,865 acres for HEMP CBD production in Nevada. Our ambition has always been to be early mover and establish our market footprint in any jurisdiction we invest in. Next year CROP plans on having the largest real estate foot print in the State of Nevada with tenanted operations in the fast-growing CBD & THC markets.”
About CROP
Crop Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada Cannabis farm, a 1,865 CBD farm, extraction in Nevada with international focuses in Jamaica and Italy and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage, US and Italian distribution rights to over 55 cannabis topical products and a portfolio of 16 Cannabis brands.
Disclaimer for Forward-Looking Information
Certain statements in this press release related to the Offering, the securities issuable thereunder and the Transaction are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected yield from The Esmeralda Property; the technological effects of The Esmeralda Property on production; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
Company Contact
Michael Yorke – CEO & Director
E-mail: info@cropcorp.com
Website: http://www.cropcorp.com
Phone: +1-(604)-484-4206
- Published in Business, CROP Infrastructure, Medical Marijuana, News Home
Tetra Bio-Pharma Takes One Step Closer to the Commercialization of Cannabis Oil-Based Retail Products
Momentum Public Relations
Press Release: September 24, 2018
Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), has made significant progress in its clinical trial for PPP005 the cannabis oil-based capsules destined for the natural health products market.
Tetra and its clinical research partner, Santé Cannabis, announced that the clinical trial in non-cancer chronic pain patients will be completed later this autumn as promised. This was the first clinical trial of its kind in evaluating the safety and efficacy of different doses and ratios of cannabis oils versus placebo. The study included a dose titration phase (gradually bringing patients to the required dose) allowing us to better understand the side effect profile of the oils as well as the development of tolerance to these effects. Thus far, no other company in the medical cannabis space has undertaken such an exhaustive study to understand the therapeutic benefits and side effects of a cannabis oil-based capsule.
Dr. Chamberland, interim CEO and CSO added, “We continue to deliver on our business model that provides for evidence-based research to support the usage of cannabis-derived products and provide the medical community with the data they have been demanding from this sector. The trial has already provided unique valuable clinical data on both safe and efficacious dose levels of CBD and THC-CBD oils. This data will allow Tetra to advance to the next phase of product development wherein the company is developing products for its commercial partner Genacol Corporation Canada, as well as food supplements for the retail market and finally, our capsules that we intend to use in the treatment of chronic and cancer related pain. Tetra has already established itself as a trailblazer in the natural health product segment with the announcement of our intention to launch a Hemp Energy Drink and we intend to build on that momentum.”
About Tetra Bio-Pharma Inc.
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
For more information visit: www.tetrabiopharma.com
- Published in Life Sciences, Medical Marijuana, News Home, Tetra Bio Pharma
CROP Boosts Nevada CBD Farm to 1,865 Acres
Momentum Public Relations
Press Release: September 24, 2018
CROP Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) announced today that its subsidiary, Elite Ventures Group LLC, has signed a 3-year lease agreement for 800 additional acres of turn key pivot-irrigated agricultural property. The lease cost will be $550 USD per acre in 2019 and $700 USD per acre 2020 forward, paid quarterly commencing in March 2019. The property is in close proximity to CROP’s existing 1,065-acre Hemp CBD Farm in Nye County Nevada.
The combined Nevada properties, including the original one of 315 acres, have a total pivoted area of 1,340 acres but will require the installation of additional pivots and water wheels at a cost of $300,000 USD. Seasonal fertilizer, planting and seed costs are not expected to exceed $600,000 USD. All harvesting and commercial drying equipment have been paid for during the 2018 season.
According to cannabis industry analysts the Brightfield Group, it is estimated the hemp-CBD market alone could hit $22 billion by 2022.
The two existing strains planted during the 2018 season with approximately 12-19% CBD will be planted for 2019 along with 3 additional genetics in the same range of CBD. The farm will be planted and maintained to be organic to ensure the end product is to the specification of interested buyers.
CROP CEO, Michael Yorke, stated: “CROP is preparing for the upcoming Hemp Farming Act of 2018 which would remove hemp’s controlled substance designation, thus legalizing the crop under federal law, and allowing CBD isolate to be sold across all 50 states and exported internationally. As we enter the next phase of project development in Nevada we look forward to building our GMP extraction facility and introducing our made in America CBD Isolate to infuse in to our recently announced CannaDrink beverages and licensed topical lines.”
Yorke concluded: “CROP has the largest real estate foot print in Nevada dedicated to hemp-CBD. Once the additional upgrades are completed, we anticipate that our tenant and brand licensee will have 1,340 acres under irrigation. With two crops expected annually in 2019 we foresee a harvest potential of approximately 2,680,000 lbs of CBD flower. We expect to comfortably use funds from our 2018 harvest (next 30-60 days) to organically grow into the projects new foot print.”
CROP Nevada Hemp Initiatives For 2019
- Develop 300 acres additional pivots on newly leased land as per announced as per August 22, 2018
- Planting of 1,340 acres of High CBD Hemp strains
- Initial 1-ton per day processing capability GMP ISO 9000 extraction facility for pharmaceutical grade CBD
Hemp Farming Act of 2018
The Bill, supported by Senate Majority Leader Mitch McConnell, is awaiting congressional approval, which would replace the 2017 Farm Bill, which expires on September 30th. The full legalization of hemp would open the door for investment and provide access to a full range of financial, market development and advisory services that have been unavailable because of its classification as a controlled substance. These services would include small business loans (SBA’s), federal crop insurance, access to banking, USDA research.
About CROP
Crop Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California and Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of assets including Canna Drink a cannabis infused functional beverage, US and Italian distribution rights to over 55 cannabis topical products and a portfolio of 16 Cannabis brands.
Company Contact
Michael Yorke – CEO & Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
- Published in Business, CROP Infrastructure, Life Sciences, Medical Marijuana, News Home
North Bud Farms Launches “CEO Verified” Discussion Forum on AGORACOM to Act as Primary Investor Social Media Platform
Momentum Public Relations
Press Release: September 21, 2018
North Bud Farms Inc. (“NORTHBUD” or the “Company”) (CSE:NBUD) is pleased to announce the launch of a “CEO Verified” Discussion Forum on AGORACOM. The forum will serve as the Company’s primary social media platform to interact with both shareholders and the broader investment community in a fully moderated environment.
The Company will also receive significant exposure through millions of content brand insertions on the AGORACOM network and extensive search engine marketing over the next 12 months. In addition, exclusive sponsorships of invaluable digital properties such as AGORACOM TV, the AGORACOM home pageand the AGORACOM Twitter account will serve to significantly raise the brand awareness of the Corporation among small cap investors.
MODERATED DISCUSSION FOR PUBLIC COMPANY EXECUTIVES AND SHAREHOLDERS
AGORACOM “CEO Verified” provides the first ever identity verification of small cap executives on a finance platform. For the first time ever, small cap CEO’s and other company officers can post or communicate within a discussion forum without the risk of impersonation leading to catastrophic consequences. As the ultimate influencers of their own companies, “CEO Verified” Forums will create incredible levels of engagement between companies and investors that have long desired civilized, constructive and factual conversation, with no limitations as to the number of characters.
Posts to AGORACOM are shareable on Twitter, Facebook and LinkedIn, which enables the Company to continue utilizing these channels while making AGORACOM the primary HUB of investor engagement.
There are no log-in requirements for investors to visit the forum and read posts. Those wishing to post questions, comments and interact with company officers can quickly log-in using their Facebook or LinkedIn accounts, or create an anonymous new user account.
The North Bud Farms Discussion Forum can be found at:
https://agoracom.com/ir/NorthBudFarms
Verified officer at launch:
- Ryan Brown, CEO
- Edward Miller, VP of Investor Relations
Ryan Brown, Founder and CEO stated, “Social media participation is very important for growth companies such as ours and AGORACOM forums are purpose built to facilitate intelligent discussions. I encourage everyone to read and participate in our CEO Verified Discussion Forum to create great, vibrant and constructive discussion for the long-term benefit of everyone.”
George Tsiolis, AGORACOM Founder stated “This is a service that is long overdue for small cap companies, executives and long-term shareholders that have had no choice but to watch their company message get hijacked on unmonitored forums by unscrupulous investors. CEO Verified Discussion Forums is the killer solution and it is free, so every small cap CEO in North America should be using it and every small cap shareholder should be demanding it.”
SHARES FOR SERVICES
The Company intends to issue common shares in the capital of the Company (the “Common Shares”) to AGORA in exchange for the Services. Pursuant to the terms of the Agreement, the Company will be issuing a total fee of $50,000 (plus HST), to be paid as follows:
- $50,000 + HST to be paid via Shares For Services
- $10,000 + HST Shares For Services upon Commencement September 15, 2019 for initial set up of HUB, marketing materials and search engine programs.
- $10,000 + HST Shares For Services at end of Third Month December 15, 2018
- $10,000 + HST Shares For Services at end of Sixth Month March 15, 2019
- $10,000 + HST Shares For Services at end of Ninth Month June 15, 2019
- $10,000 + HST Shares For Services at end of Twelfth Month September 15, 2019
The number of Common Shares to be issued at the end of each period will be determined by using the closing price of the Common Shares of the Company on the Canadian Securities Exchange (“CSE”) on the first trading day following the end of each period for which the Services were provided by AGORA.
The term of the Agreement is for 12 months effective September 15, 2018 and the Agreement is subject to exchange approval.
About North Bud Farms Inc.
North Bud Farms Inc., through its wholly-owned subsidiary GrowPros MMP Inc. which was acquired in February 2018, is pursuing a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR). North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.
For more information visit: www.northbud.com
About AGORACOM
AGORACOM is the pioneer of online marketing, broadcasting, conferences and investor relations services to North American small and mid-cap public companies, with more than 300 companies served. AGORACOM is the home of more than 767K investors that visited 5.2 million times and read 53 million pages of information every year. The average duration of visit of 8min 43sec is more than double that of global financial sites, which can be attributed to the implementation and enforcement of the strongest moderation rules in the industry (All Metrics Average 2008 -2017).
AGORACOM traffic ranks within the top 0.5% of all websites around the world. These traffic results are independently tracked and verified by Google analytics. AGORACOM traffic can be attributed to its strategy of maintaining the cleanest, moderated small-cap discussion, as well as, implementation of the first ever Investor Controlled Stock Discussion Forums in 2007. 10 years later, in 2017, AGORACOM launched the first ever “CEO Verified” Discussion Forums to allow Small Cap CEO’s and Company officers to post comments in a fully verified, moderated and social media shareable environment.
Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms’ final long form prospectus dated August 21, 2018 which is available under the issuer’s SEDAR profile at www.sedar.com.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
investors@northbud.com
- Published in Medical Marijuana, News Home, NorthBud
North Bud Farms Closes $944,500 Private Placement
Momentum Public Relations
Press Release: September 20, 2018
North Bud Farms Inc. (CSE: NBUD) (the “Corporation“), is pleased to announce the closing of a non-brokered private placement offering (the “Private Placement“) consisting of 3,778,000 units (“Units“), at a price of $0.25 per Unit, for gross proceeds of $944,500. Each Unit is comprised of one Common Share and one-half (1/2) of a Common Share purchase warrant, with each whole warrant entitling the holder hereof to acquire one additional Common Share at a price of $0.40 per Common Share until September 20, 2020. No fees or commissions were paid in connection with the Private Placement. The terms of the Private Placement are the same as the Corporation’s previously-completed private placement (July 25, 2018, as disclosed in the Corporation’s prospectus dated August 21, 2018).
Mr. Andre Audet, the Chairman of the Corporation, participated in the Private Placement by subscribing for 200,000 Units (the “Insider’s Participation“). The Insider’s Participation is exempt from the formal valuation and minority shareholder approval requirements provided under Multilateral Instrument 61-101 Protection of Minority Holders in Special Transactions (“MI 61-101“) in accordance with sections 5.5(a) and 5.7(a) of MI 61-101. The exemption is based on the fact that neither the fair market value of the Insider’s Participation nor the consideration paid by such insider exceeds 25% of the Corporation’s market capitalization. The Corporation did not file a material change report at least 21 days prior to the completion of the Private Placement since the Insider’s Participation was not determined at that moment.
The Corporation intends to use the proceeds of the Private Placement to continue to advance the license application of GrowPros MMP Inc. under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and for general working capital purposes.
The securities acquired by the subscribers are subject to a hold period of four months plus one day from the closing date, ending on January 21, 2019, except as permitted by applicable securities legislation.
About North Bud Farms Inc.
North Bud Farms Inc., through its wholly-owned subsidiary GrowPros MMP Inc. which was acquired from Tetra Bio-Pharma Inc. (TSX-V: TBP) (OTCQB: TBPMF) in February 2018, is pursuing a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR). North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.
For more information visit: www.northbud.com
- Published in Medical Marijuana, News Home, NorthBud
North Bud Farms to trade on CSE Sept. 20
Momentum Public Relations
Press Release: September 19, 2018
The common shares of North Bud Farms Inc. have been approved for listing on the Canadian Securities Exchange.
Listing and disclosure documents will be available on the CSE website on the trading date.
North Bud Farms, through its wholly owned subsidiary, GrowPros MMP Inc., is pursuing a licence under the Access to Cannabis for Medical Purposes Regulations (ACMPR). North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of agricultural land in Low, Que. North Bud Farms will be focused on pharmaceutical- and food-grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October, 2019.
Issuer: North Bud Farms
Security type: common shares
Symbol: NBUD
Number of securities issued and outstanding: 51,768,000
Number of securities reserved for issuance: 11,629,000
CSE sector: life sciences
Cusip No.: 658043 10 4
ISIN: CA 658043 10 4 8
Board lot: 500
Trading currency: Canadian dollar
Trading date: Sept. 20, 2018
Other exchanges: not applicable
Fiscal year-end: Nov. 30
Transfer agent: Computershare Investor Services Inc.
- Published in Medical Marijuana, News Home, NorthBud
Tetra spinout North Bud to start trading tomorrow
Momentum Public Relations
Press Release: September 19, 2018
North Bud Farms Inc. (“NORTHBUD” or the “Company“) is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange (“CSE”) at the opening of the market on Thursday, September 20, 2018 under the stock symbol “NBUD”.
“We are proud to achieve this milestone in advance of the historic legalization of Cannabis in Canada on October 17, 2018 and less than 10 months since the Company’s inception which is a testament to the dedication and execution of our experienced management team,” said Ryan Brown, Founder and CEO of North Bud Farms.
Concurrently with the CSE listing, the Company also announces that the board of directors has authorized the grant of 5,100,000 incentive stock options to certain of its directors, officers, employees and consultants. Each such option entitles the holder to acquire one common share for a period of 5 years at an exercise price of $0.25 per common share.
About North Bud Farms Inc.
North Bud Farms Inc., through its wholly-owned subsidiary GrowPros MMP Inc. which was acquired from Tetra Bio-Pharma Inc. (TSX-V: TBP) (OTCQB: TBPMF) in February 2018, is pursuing a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR). North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.
For more information visit: www.northbud.com
Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
- Published in Life Sciences, Medical Marijuana, News Home, Tetra Bio Pharma